The large-scale vaccination work started in the United States on the 14th was frequent. After successive incidents of allergy to the recipients and the return of vaccines to the factory, many state governments in the United States complained that the shipment of vaccines had decreased significantly.
The Trump administration tried to blame Pfizer for production problems, but Pfizer refused to “take the blame”, denied that there was a problem with production capacity, saying that the number of vaccines could be provided far more than the number of vaccines being distributed.
Many states complain about vaccine supply cuts, and the Trump administration “blame” Pfizer.
According to NPR and The Washington Post on the 18th, officials in several states in the United States revealed that they were notified on Wednesday (16th) that the number of the second batch of vaccines by Pfizer next week will be significantly reduced.
Washington Gov. Jay Inslee said the CDC had told the state that it would “cut vaccine distributions by 40% next week and that all states would have a similar situation”, but the Trump administration did not give a specific explanation.
“It’s devastating news and frustrating,” Inslee said.
“We need accurate, predictable data to plan vaccinations to ensure that vaccinations go smoothly.”
Iowa’s Department of Public Health also said that “the initial number of COVID-19 vaccines may be reduced by 30%.” Idaho health department claims they have also received news that the distribution of Pfizer’s vaccine will be reduced from 17,550 to 9,750 doses next week.
However, they said that they would not change the focus of the current vaccination work and would continue to give priority to medical staff.
Michigan, Connecticut, Georgia, Illinois, Kansas, Montana, Nebraska, Nevada, New Hampshire and Indiana all reported significant declines in vaccine supplies, according to the Associated Press.
Michael Pratt, spokesman of the U.S. Department of Health and Human Services, denied changing the number of vaccine allocations in each state after states exposed the decline in vaccine supply.
He explained that the government is still moving forward as planned to vaccinate about 20 million Americans enough by the end of the year.
On Wednesday, Alex Azar, the Secretary of Health and Human Services, “blank” Pfizer, claiming that it was because Pfizer’s production difficulties.
“The central issue of this matter is whether Pfizer can guarantee sufficient production capacity by the specified date.” “They [Pfizer] have identified production difficulties and we have been working with them to determine what kind of help we should provide to ensure an adequate supply of vaccines,” Azar said.
Azar also revealed that the Trump administration is pushing for the distribution of millions of doses of vaccine.” Next week, we will distribute about 2 million more doses of the coronavirus vaccine.” They will also distribute nearly 5.9 million doses of Modner vaccine once the Modna vaccine is urgently authorized.
A day later, in an interview with CNBC, Hazard said again.
Pfizer has cut its production forecast from 100 million doses to 50 million doses this year, and he claims that he needs to “be more knowledge” about Pfizer’s production capacity.
“I really hope we don’t talk about Pfizer anymore.” Hazard did not forget to remind that there are other vaccines available in the United States.
Pfizer: There is no problem with production capacity. The warehouse is full of vaccines.
However, in the face of the Trump administration’s “blaming the blame”, Pfizer refused to “take the blame”. “There are no issues with Pfizer’s COVID-19 vaccine production, and vaccine shipments have not been suspended or delayed,” said Albert Bourla, CEO of Pfizer.
Bora said Pfizer had provided every shipment requested by the Trump administration in a timely manner.
In a statement on Thursday, Pfizer stressed again that the company has not encountered any production difficulties and that the number of vaccines can be provided far more than the number of vaccines being distributed.
In the past week, Pfizer has shipped 2.9 million doses of the coronavirus vaccine and said it is still confident that it will provide 50 million doses to the world this year and will reach 1.3 billion doses next year.
Pfizer said that there are millions of doses of COVID-19 vaccine in its warehouse, and so far, the company has not received any shipping instructions to increase the dose.
On December 11th local time, the U.S. Food and Drug Administration (FDA) urgently approved the coronavirus vaccine developed by Pfizer and BioNTech in Germany.
On the 14th, the first round of large-scale vaccination of this vaccine was officially launched in the United States. However, since then, the status of vaccination has been frequent.
According to Reuters, a medical staff in Alaska, USA, developed a severe allergic reaction after being vaccinated against Pfizer on the 15th.
On the 8th, two medical staff in the United Kingdom also had serious adverse reactions after being vaccinated against the same Pfizer vaccine.
Just one day later, the vaccination program was exposed to new conditions.” Gustave Perna, CEO of Operation Warp Speed and commander of the U.S. Army Equipment Command, said on the same day that 3,000 doses of Pfizer vaccines in two U.S. states were quarantined and returned to manufacturers due to the low storage temperature during transportation.
